Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2026)

Autolus Therapeutics (AUTL) has 8 years of Other Non-Current Assets data on file, last reported at $1.0 million in Q4 2025.

• Quarterly Other Non-Current Assets rose 7.17% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 7.17% YoY) and the FY2025 annual result came in at $1.0 million, up 7.17% from the prior year.
• Other Non-Current Assets was little changed at $1.0 million in Q4 2025, from $1.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.3 million in Q2 2025 to a low of $943000.0 in Q3 2023.
• A 5-year average of $1.7 million and a median of $1.8 million in 2021 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets tumbled 54.83% — and 2025, when it soared 438.18%.
• Tracing AUTL's Other Non-Current Assets over 5 years: stood at $2.4 million in 2021, then fell by 7.87% to $2.2 million in 2022, then sank by 54.83% to $983000.0 in 2023, then declined by 2.03% to $963000.0 in 2024, then gained by 7.17% to $1.0 million in 2025.
• The last three Other Non-Current Assets figures came in at $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.